Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.

MLA

Tran, Misha C., et al. “Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.” Clinical Lung Cancer, vol. 24, no. 3, May 2023, pp. e117–21. EBSCOhost, https://doi.org/10.1016/j.cllc.2023.01.003.

APA

Tran, M. C., Strohbehn, G. W., Karrison, T. G., Rouhani, S. J., Segal, J. P., Shergill, A., Hoffman, P. C., Patel, J. D., Garassino, M. C., Vokes, E. E., & Bestvina, C. M. (2023). Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression. Clinical Lung Cancer, 24(3), e117–e121. https://doi.org/10.1016/j.cllc.2023.01.003

Chicago

Tran, Misha C, Garth W Strohbehn, Theodore G Karrison, Sherin J Rouhani, Jeremy P Segal, Ardaman Shergill, Philip C Hoffman, et al. 2023. “Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.” Clinical Lung Cancer 24 (3): e117–21. doi:10.1016/j.cllc.2023.01.003.